Prisma Health - Academic Profile | RDL Research Database

Publications

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Michael A. Postow , Jason Chesney , Anna C. Pavlick +18 more

The objective-response rate and the progression-free survival among patients with advanced melanoma who had not previously received treatment were significantly greater with niv...

2015 New England Journal of Medicine 2716 citations

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Arash Jamshidi , Roger Jiang , M.C. Liu +97 more

2020 Annals of Oncology 1365 citations

Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

Michael S. Conte , Andrew W. Bradbury , Philippe Kolh +56 more

2019 European Journal of Vascular and Endo... 1315 citations

Affiliated Researchers

Institution Info

Type: healthcare
Country: US
Publications: 3
Citations: 5,396

External Links

Identifiers

ROR: https://ror.org/03n7vd314

Publications

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

Affiliated Researchers

Jeffrey K. Giguere

Ross M. Michels

Bruce H. Gray

Spence Taylor

Institution Info

External Links

Identifiers